English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Alain Gelibter*,1, Mario Occhipinti1 , Simona Pisegna1, Alessio Cortellini2,3, Enrico Cortesi1 & Paolo Marchetti1,4 1Medical Oncology Unit, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy 2Medical Oncology Unit, St. Salvatore Hospital, L’Aquila, Italy 3Department of Biotechnological & Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy 4U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant’Andrea, Rome, Italy *Author for correspondence: alain.gelibter@uniroma1.it

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer